Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene delivery

Journal of Clinical Investigation

Volumn 104, Issue 1, 1999, Pages 21-29

  Maurice, John P ^a   Hata, Jonathan A ^a   Shah, Ashish S ^a   White, David C ^a   McDonald, Patricia H ^a   Dolber, Paul C ^a   Wilson, Katrina H ^a   Lefkowitz, Robert J ^a   Glower, Donald D ^a   Koch, Walter J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR;

ADENOVIRUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HEART FUNCTION; HEART MUSCLE; HEART PERFORMANCE; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0032745831     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6026     Document Type: Article

References (29)

1. Cohn, J.N., et al. 1997. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation. 95:766-770.
2. Brodde, O.E. 1993. Beta-adrenoceptors in cardiac disease. Pharmacol. Ther. 60:405-430.
3. Bristow, M.R., et al. 1982. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N. Engl. J. Med. 307:205-211.
4. Ping, P., Anzai, T., Gao, M., and Hammond, H.K. 1997. Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. Am. J. Physiol. 273:H707-H717.
5. Bristow, M.R., et al. 1993. Reduced β1 receptor messenger RNA abundance in the failing human heart. J. Clin. Invest. 92:2737-2745.
6. 1-adrenergic receptors in the failing heart. Circulation. 87:454-463.
7. Bristow, M.R., and Lowes, B.D. 1994. Low-dose inotropic therapy for ambulatory heart failure. Coron. Artery Dis. 5:112-118.
8. 2-adrenergic receptor. Science. 264:582-586.
9. Turki, J., et al. 1996. Myocardial signaling defects and impaired cardiac function of a human β2-adrenergic receptor polymorphism expressed in transgenic mice. Proc. Natl. Acad. Sci. USA. 93:10483-10488.
10. Akhter, S.A., et al. 1997. Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc. Natl. Acad. Sci. USA. 94:12100-12105.
11. Kass-Eisler, A., et al. 1993. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 90:11498-11502.
12. French, B.A., Mazur, W., Geske, R.S., and Bolli, R. 1994. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation. 90:2414-2424.
13. Magovern, C.J., et al. 1996. Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. Ann. Thorac. Surg. 62:425-433.
14. Barr, E., et al. 1994. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1:51-58.
15. Giordano, F.J., et al. 1996. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat. Med. 2:534-539.
16. Hajjar, R.J., et al. 1998. Modulation of ventricular function through gene transfer in vivo. Proc. Natl Acad. Sci. USA. 95:5251-5256.
17. Drazner, M.H., et al. 1997. Potentiation of β-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes. J. Clin. Invest. 99:288-296.
18. Kypson, A.P., et al. 1998. Ex vivo adenoviral-mediated gene transfer to the transplanted adult rat heart. J. Thorac. Cardiovasc. Surg. 115:623-630.
19. Koch, W.J., et al. 1995. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science. 268:1350-1353.
20. Silvestry, S.C., et al. 1996. The in vivo quantification of myocardial performance in rabbits: a model for evaluation of cardiac gene therapy./ Mol. Cell. Cardiol. 28:815-823.
21. Maurice, J.P., et al. 1999. Molecular β-adrenergic signaling abnormalities in failing rabbit hearrs after infarction. Am. J. Physiol. 276:H1853-1860
22. Engelhardt, J.F., Ye, X., Doranz, B., and Wilson, J.M. 1994. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA. 91:6196-6200.
23. Yang, Y., Jooss, K.U., Su, Q., Ertl, H.C.J., and Wilson, J.M. 1996. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3:137-144.
24. Donahue, J.K., Kikkawa, K., Johns, D.C., Marban, E., and Lawrence, J.H. 1997. Ultrarapid, highly efficient viral gene transfer to the heart. Proc. Natl. Acad Sci. USA. 94:4664-4668.
25. 2-adrenergic receptor to donor hearts enhances cardiac function. Gene Ther. In press.
26. 2-adrenergic receptors differentially affects cardiac hypertrophy and function in Gαq overexpressing mice. Proc. Natl. pAcad. Sci. USA. 96:6400-6405.
27. Liggett, S.B., et al. 1998. The ile164 β2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J. Clin. Invest. 102:1534-1539.
28. Dipla, K., Mattiello, J.A., Jeevanandam, V., Houser, S.R., and Margulies, K.B. 1998. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 97:2316-2322.
29. Zafeiridis, A., Jeevanandam, V., Houser, S.R., and Margulies, K.B. 1998. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 98:656-662.